Follow the people · Insider
Amy Suzon Chappell
Amy Suzon Chappell files insider transactions with the SEC as a director of Biovie (BIVI). We hold 1 disclosed purchase or sale filed since 9 January 2026, 1 of them in the last 90 days.
- Files forBIVI
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure28 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 5 January 2026 — 28 August 2026Director · Biovie (BIVI)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
3 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 727 shares of BiovieSEC Form 428 August 2026Common Stock · traded 28 August 2026 · filed 28 August 2026
- was granted 57,500 shares of Biovie (a derivative holding)SEC Form 49 January 2026Stock Option (right to buy) · traded 5 January 2026 · filed 9 January 2026
- was granted 57,500 shares of Biovie (a derivative holding)SEC Form 49 January 2026Stock Option (right to buy) · traded 5 January 2026 · filed 9 January 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.